DNM3
Basic information
Region (hg38): 1:171817887-172418466
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 1 | 5 | |||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 3 | 1 |
Variants in DNM3
This is a list of pathogenic ClinVar variants found in the DNM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-171841667-G-T | not specified | Uncertain significance (Aug 07, 2024) | ||
1-171841679-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
1-171921755-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
1-171921768-C-T | not specified | Uncertain significance (May 20, 2024) | ||
1-171921803-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
1-171987686-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
1-171988980-A-T | not specified | Uncertain significance (Nov 06, 2023) | ||
1-171988993-T-C | not specified | Uncertain significance (Oct 20, 2021) | ||
1-171988998-G-T | not specified | Uncertain significance (Jul 27, 2022) | ||
1-171989029-G-T | not specified | Uncertain significance (Oct 12, 2022) | ||
1-171989042-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
1-172032494-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
1-172032495-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
1-172033135-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
1-172033176-G-T | not specified | Uncertain significance (Aug 01, 2022) | ||
1-172033204-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
1-172033205-G-A | Likely benign (Apr 01, 2023) | |||
1-172038338-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
1-172038406-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
1-172038413-A-C | not specified | Uncertain significance (Apr 19, 2023) | ||
1-172038425-C-A | Likely benign (Sep 01, 2023) | |||
1-172042025-G-T | not specified | Uncertain significance (Apr 08, 2022) | ||
1-172042088-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
1-172042109-A-G | not specified | Uncertain significance (Jan 24, 2023) | ||
1-172042142-A-C | DNM3-related condition | Uncertain significance (Mar 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNM3 | protein_coding | protein_coding | ENST00000358155 | 21 | 576986 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00242 | 0.998 | 124647 | 0 | 24 | 124671 | 0.0000963 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.70 | 314 | 480 | 0.654 | 0.0000260 | 5650 |
Missense in Polyphen | 104 | 189.14 | 0.54984 | 2300 | ||
Synonymous | -0.143 | 179 | 177 | 1.01 | 0.00000971 | 1670 |
Loss of Function | 4.22 | 13 | 42.8 | 0.304 | 0.00000231 | 508 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000170 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000291 | 0.000278 |
European (Non-Finnish) | 0.000102 | 0.0000973 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000142 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Most probably involved in vesicular trafficking processes, in particular endocytosis (By similarity). {ECO:0000250}.;
- Pathway
- Synaptic vesicle cycle - Homo sapiens (human);Endocytosis - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Synaptic Vesicle Pathway;Developmental Biology;Signal Transduction;Recycling pathway of L1;Vesicle-mediated transport;Membrane Trafficking;Toll-Like Receptors Cascades;MHC class II antigen presentation;Innate Immune System;Immune System;Adaptive Immune System;Retrograde neurotrophin signalling;Clathrin-mediated endocytosis;Signaling by NTRK1 (TRKA);Signaling by NTRKs;L1CAM interactions;Axon guidance;Toll Like Receptor 4 (TLR4) Cascade;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.243
Intolerance Scores
- loftool
- 0.338
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.72
Haploinsufficiency Scores
- pHI
- 0.255
- hipred
- Y
- hipred_score
- 0.680
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.770
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnm3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- endocytosis;synapse assembly;synaptic vesicle budding from presynaptic endocytic zone membrane;receptor internalization;filopodium assembly;regulation of synapse structure or activity;positive regulation of filopodium assembly;negative regulation of dendritic spine morphogenesis;postsynaptic neurotransmitter receptor internalization;postsynapse organization;positive regulation of synaptic vesicle recycling
- Cellular component
- photoreceptor inner segment;cytoplasm;Golgi apparatus;microtubule;plasma membrane;postsynaptic density;membrane;axon;cytoplasmic vesicle;synaptic cleft;dendritic spine;dendritic spine head;synapse;postsynaptic membrane;perinuclear region of cytoplasm;apical tubulobulbar complex;basal tubulobulbar complex;extracellular exosome;presynapse;postsynaptic endocytic zone membrane;glutamatergic synapse
- Molecular function
- GTPase activity;protein binding;GTP binding;microtubule binding;type 1 metabotropic glutamate receptor binding;type 5 metabotropic glutamate receptor binding;nitric-oxide synthase binding;structural constituent of postsynapse